+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lipid Abnormalities in Persons Living With HIV Infection



Lipid Abnormalities in Persons Living With HIV Infection



Canadian Journal of Cardiology 2019



Lipid abnormalities are prevalent among persons living with HIV infection and contribute to increasing the risk of cardiovascular events. Antiretroviral therapy (ART) is associated with lipid abnormalities, most commonly hypertriglyceridemia, but also increases in low-density lipoprotein cholesterol and total cholesterol. Different classes of ART, and different drugs within classes, have differing effects on lipid levels, but in general newer drugs have more favourable effects compared with older ones. Low-level inflammation and chronic immune activation act on lipids through a variety of mechanisms to make them more atherogenic. As a consequence, risk is higher than would be expected for any given cholesterol level. Clinical outcome trials of cholesterol-lowering therapies have not yet been completed in people living with HIV, so that treatment decisions depend on extrapolation from studies in uninfected populations. Traditional risk assessment tools underestimate cardiovascular risk in individuals with HIV. Statins are the mainstay of lipid-lowering drug treatment; however, drug-drug interactions with ART must be considered. Simvastatin and lovastatin are contraindicated in patients taking protease inhibitors, and the dose of atorvastatin and rosuvastatin should be limited to 40 mg and 10 mg/d with some ART combinations. Switching from older forms of ART to lipid-friendly newer ones is a useful strategy as long as virologic suppression is maintained, but adding a statin lowers low-density lipoprotein cholesterol more effectively. Studies indicate that lipid abnormalities are not treated as aggressively in individuals living with HIV as they are in uninfected people, making this an opportunity to improve care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446878

Download citation: RISBibTeXText

PMID: 30704819

DOI: 10.1016/j.cjca.2018.11.005


Related references

Hematological abnormalities associated with pulmonary tuberculosis in persons living with human immunodeficiency virus infection in Côte d'Ivoire. Medecine Tropicale 70(4): 415-416, 2012

An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. Journal of Infectious Diseases 207 Suppl 1: S1-S6, 2013

Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. Journal of Clinical Microbiology 40(10): 3822-3825, 2002

Serum lipid concentration and subjective evaluation of well-being in elderly persons living at home. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 33(9): 676-680, 1996

HCV co-infection is associated with metabolic abnormalities among HAART naive HIV-infected persons. Nigerian Journal of Clinical Practice 20(7): 799-803, 2017

Bone mineral abnormalities in persons with HIV infection: signal or noise?. Aids Reader 16(8): 407-10, 413-8, 2006

Heart failure in persons living with HIV infection. Current Opinion in HIV and Aids 12(6): 534-539, 2017

Screening for Cancer in Persons Living with HIV Infection. Trends in Cancer 2(8): 416-428, 2018

Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV. Pathogens and Immunity 2(3): 376-403, 2017

Successful cognitive aging in persons living with HIV infection. Journal of Neurovirology 17(1): 110-119, 2011

Self-reported signs of lipodystrophy by persons living with HIV infection. International Journal of Std & Aids 13(6): 393-398, 2002

HCV infection and lipid abnormalities. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 4: 139-144, 2011

Lipid abnormalities in hiv infection. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Thb 207, 1990

HIV transmission rates from persons living with HIV who are aware and unaware of their infection. Aids 26(7): 893-896, 2012

Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabilitation Psychology 56(1): 77-84, 2011